+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Conjunctivitis Drug"

Allergic Rhino-Conjunctivitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Allergic Rhino-Conjunctivitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Bacterial Conjunctivitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bacterial Conjunctivitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Giant Papillary Conjunctivitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Giant Papillary Conjunctivitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hay Fever Conjunctivitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hay Fever Conjunctivitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Allergic Conjunctivitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Allergic Conjunctivitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
The Global Ophthalmic Drugs Market - Product Thumbnail Image

The Global Ophthalmic Drugs Market

  • Report
  • October 2018
  • 104 Pages
  • Global
From
Global Conjunctivitis Drugs Market 2018-2024 - Product Thumbnail Image

Global Conjunctivitis Drugs Market 2018-2024

  • Report
  • June 2018
  • 82 Pages
  • Global
From
Global Conjunctivitis Therapeutics Market 2021-2025 - Product Thumbnail Image

Global Conjunctivitis Therapeutics Market 2021-2025

  • Report
  • July 2021
  • 120 Pages
  • Global
From
From
From
From
Allergic Conjunctivitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Allergic Conjunctivitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 113 Pages
  • Global
From
Bacterial Conjunctivitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Bacterial Conjunctivitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 33 Pages
  • Global
From
Loading Indicator

The Conjunctivitis Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Conjunctivitis is an inflammation of the conjunctiva, the thin, transparent membrane that lines the inner surface of the eyelids and covers the white part of the eye. Conjunctivitis drugs are used to treat the symptoms of the condition, such as redness, itching, and discharge. These drugs can be administered topically, orally, or intravenously, depending on the severity of the condition. Commonly prescribed drugs for conjunctivitis include antibiotics, antihistamines, and corticosteroids. The Conjunctivitis Drug market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Allergan, Bausch + Lomb, Merck, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more